Ryusuke Hatae

10PUBLICATIONS
31CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical biotechnology diagnostics (incl. biosensors)Medical infection agents (incl. prions)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Mar 27, 2026
Long-term outcome of nimustine-based chemotherapy for oligodendroglioma.

Nobuhiro Hata, Ryosuke Otsuji, Daisuke Kuga

|May 16, 2025
Comparative evaluation of CAR-expressing T-, NK-, NKT-cells, and macrophages in an immunocompetent mouse glioma model.

Ryusuke Hatae, Payal B Watchmaker, Akane Yamamichi

|Mar 13, 2024
In-house molecular diagnosis of diffuse glioma updating the revised WHO classification by a platform of the advanced medical care system, Senshin-Iryo.

Nobuhiro Hata, Yutaka Fujioka, Ryosuke Otsuji

|Nov 28, 2023
Enhancing CAR-T Cell Metabolism to Overcome Hypoxic Conditions in the Brain Tumor Microenvironment.

Ryusuke Hatae, Keith Kyewalabye, Akane Yamamichi

|Dec 14, 2022
Combination bezafibrate and nivolumab treatment of patients with advanced non-small cell lung cancer.

Kentaro Tanaka, Kenji Chamoto, Sho Saeki

Pageof 2